| Date | Title | Description |
| 31.08.2026 | Clinical Laserthermia Systems AB announces completion of rights issue of units | Clinical Laserthermia Systems AB announces completion of rights issue of units
Mon, Aug 31, 2026 16:45 CET Report this content
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUST... |
| 20.08.2026 | Clinical Laserthermia Systems AB announces outcome in rights issue of units | Clinical Laserthermia Systems AB announces outcome in rights issue of units
Thu, Aug 20, 2026 21:25 CET Report this content
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRAL... |
| 18.08.2026 | Clinical Laserthermia Systems AB Enters into Top-down Guarantee Agreement in Ongoing Rights Issue of Units | Clinical Laserthermia Systems AB Enters into Top-down Guarantee Agreement in Ongoing Rights Issue of Units
Tue, Aug 18, 2026 08:30 CET Report this content
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR ... |
| 04.08.2026 | The Subscription Period in Clinical Laserthermia Systems AB’ Rights Issue of Units Begins Today | The Subscription Period in Clinical Laserthermia Systems AB’ Rights Issue of Units Begins Today
Tue, Aug 04, 2026 08:30 CET Report this content
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UN... |
| 15.07.2026 | Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 7 of 11 | Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 7 of 11
Wed, Jul 15, 2026 11:30 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR I... |
| 01.07.2026 | Today is the first day of the seventh exercise period for Bio-Works Technologies AB's warrants of series TO 2 | Today is the first day of the seventh exercise period for Bio-Works Technologies AB's warrants of series TO 2
Wed, Jul 01, 2026 08:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR I... |
| 17.04.2026 | Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 6 of 11 | Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 6 of 11
Fri, Apr 17, 2026 14:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR I... |
| 01.04.2026 | Today is the first day of the sixth exercise period for Bio-Works Technologies AB's warrants of series TO 2 | Today is the first day of the sixth exercise period for Bio-Works Technologies AB's warrants of series TO 2
Wed, Apr 01, 2026 08:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR IND... |
| 25.03.2026 | Correction: BiBBInstruments AB (publ) publishes updated information document in connection with rights issue – incorrect ISIN code for the share | Correction: BiBBInstruments AB (publ) publishes updated information document in connection with rights issue – incorrect ISIN code for the share
Wed, Mar 25, 2026 21:54 CET Report this content
BiBBInstruments AB (publ) (“BIBB” or the “Compa... |
| 11.02.2026 | SyntheticMR’s rights issue has been registered – conversion of BTA into shares | SyntheticMR’s rights issue has been registered – conversion of BTA into shares
Wed, Feb 11, 2026 16:51 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA... |
| 04.02.2026 | SyntheticMR publishes the outcome of the rights issue | SyntheticMR publishes the outcome of the rights issue
Wed, Feb 04, 2026 15:16 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANAD... |
| 22.01.2026 | SyntheticMR Secures Capital for Global AI Neurodiagnostics Expansion Amidst Strong Q4 Revenue Surge | SyntheticMR AB launches a SEK 32.8 million rights issue. Shareholders approved the capital raise. This funding fuels strategic growth. Preliminary Q4 2025 financials reveal a 43% revenue surge. The company leverages its Combinostics acquisi... |
| 19.01.2026 | Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 5 of 11 | Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 5 of 11
Mon, Jan 19, 2026 12:30 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR I... |
| 19.01.2026 | SyntheticMR AB publishes information document regarding the rights issue | SyntheticMR AB publishes information document regarding the rights issue
Mon, Jan 19, 2026 13:51 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN, C... |
| 02.01.2026 | Bio-Works Fuels Growth with Key Orders and Capital Raise | Bio-Works Technologies solidifies market presence. New SEK 4 million WorkBeads orders from a key Indian client underscore robust biopharmaceutical purification demand. These orders bolster future revenue. Simultaneously, the firm launched i... |
| 02.01.2026 | Today is the first day of the fifth exercise period for Bio-Works Technologies AB's warrants of series TO 2 | Today is the first day of the fifth exercise period for Bio-Works Technologies AB's warrants of series TO 2
Fri, Jan 02, 2026 08:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR IND... |
| 18.12.2025 | Notice of extra general meeting in SyntheticMR AB (publ) | Notice of extra general meeting in SyntheticMR AB (publ)
Thu, Dec 18, 2025 09:01 CET Report this content
The shareholders of SyntheticMR AB (publ), reg. no. 556723-8877, (the "Company") are hereby invited to the extra general meet... |
| 16.10.2025 | Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 4 of 11 | Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 4 of 11
Thu, Oct 16, 2025 08:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR I... |
| 01.10.2025 | Today is the first day of the fourth exercise period for Bio-Works Technologies AB's warrants of series TO 2 | Today is the first day of the fourth exercise period for Bio-Works Technologies AB's warrants of series TO 2
Wed, Oct 01, 2025 08:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR IN... |
| 30.09.2025 | Clinical Laserthermia Systems AB Raises SEK 20.9 Million Through Full Subscription of Warrants of Series TO 8 B | Clinical Laserthermia Systems AB Raises SEK 20.9 Million Through Full Subscription of Warrants of Series TO 8 B
Tue, Sep 30, 2025 13:35 CET Report this content
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, I... |
| 15.07.2025 | Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 3 of 11 | Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 3 of 11
Tue, Jul 15, 2025 12:15 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR I... |
| 09.07.2025 | Katalysen Ventures AB publishes outcome of rights issue | Katalysen Ventures AB publishes outcome of rights issue
Wed, Jul 09, 2025 21:11 CET Report this content
The Board of Directors of Katalysen Ventures AB ("Katalysen" or the "Company"), today announces the outcome of the r... |
| 03.07.2025 | Navigating the Financial Waters: Bio-Works and Katalysen Ventures Take Center Stage | In the world of finance, every tick of the clock can signal opportunity or peril. Recently, two companies, Bio-Works Technologies AB and Katalysen Ventures AB, have made headlines with their respective rights issues. These moves are more th... |
| 01.07.2025 | Today is the first day of the third exercise period for Bio-Works Technologies AB's warrants of series TO 2 | Today is the first day of the third exercise period for Bio-Works Technologies AB's warrants of series TO 2
Tue, Jul 01, 2025 08:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR IND... |
| 18.04.2025 | Brain+ Transitions Leadership: A New Era for Dementia Care | In the heart of Copenhagen, a significant shift is underway at Brain+ A/S. The company has appointed Devika Wood, its Chief Commercial Officer, as the new CEO. This move marks a pivotal moment in the company’s evolution from a research-focu... |
| 15.04.2025 | Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 2 of 11 | Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 2 of 11
Tue, Apr 15, 2025 17:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR I... |
| 01.04.2025 | Bio-Works: A Beacon in the Gene Therapy Landscape | In the ever-evolving world of biotechnology, Bio-Works Technologies AB stands out like a lighthouse guiding ships through foggy waters. The company has recently made headlines with significant orders for its GoBio pre-packed columns, specif... |
| 01.04.2025 | Today is the first day of the second exercise period for Bio-Works Technologies AB's warrants of series TO 2 | Today is the first day of the second exercise period for Bio-Works Technologies AB's warrants of series TO 2
Tue, Apr 01, 2025 08:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR IN... |
| 27.02.2025 | Clinical Laserthermia Systems AB raises up to SEK 37m through a directed issue for accelerated commercialization and expansion | Clinical Laserthermia Systems AB raises up to SEK 37m through a directed issue for accelerated commercialization and expansion
Thu, Feb 27, 2025 08:55 CET Report this content
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY O... |
| 02.01.2025 | The first day to exercise Bio-Works Technologies AB's warrants of series TO 2 is today | The first day to exercise Bio-Works Technologies AB's warrants of series TO 2 is today
Thu, Jan 02, 2025 11:39 CET Report this content
EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, I USA, AUSTRALIE... |
| 25.11.2024 | Watch all videos from BioStock Life Science Summit 2024 | Watch all videos from BioStock Life Science Summit 2024
Mon, Nov 25, 2024 12:06 CET Report this content
During the seventh annual BioStock Life Science Fall Summit, 30+ life science companies showcased their projects and business cases to i... |
